The Embryonic Stem Cell-Specific Transcription Factor ZFP57 Promotes Liver Metastasis of Colorectal Cancer
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Journal of Surgical Research
- Vol. 237, 22-29
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 19 references indexed in Scilit:
- Genetic and epigenetic mutations affect the DNA binding capability of human ZFP57 in transient neonatal diabetes type 1FEBS Letters, 2013
- TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancerCancer Epidemiology, 2013
- Zinc Finger Protein ZFP57 Requires Its Co-factor to Recruit DNA Methyltransferases and Maintains DNA Methylation Imprint in Embryonic Stem Cells via Its Transcriptional Repression DomainJournal of Biological Chemistry, 2012
- In Embryonic Stem Cells, ZFP57/KAP1 Recognize a Methylated Hexanucleotide to Affect Chromatin and DNA Methylation of Imprinting Control RegionsMolecular Cell, 2011
- Inhibition of aldose reductase prevents colon cancer metastasisCarcinogenesis, 2011
- Expression of insulin-like growth factor 2 in mesenchymal neoplasmsLaboratory Investigation, 2009
- A Maternal-Zygotic Effect Gene, Zfp57, Maintains Both Maternal and Paternal ImprintsDevelopmental Cell, 2008
- Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57Nature Genetics, 2008
- Identification of Zfp-57 as a downstream molecule of STAT3 and Oct-3/4 in embryonic stem cellsBiochemical and Biophysical Research Communications, 2005
- Identification and Characterization of ZFP-57, a Novel Zinc Finger Transcription Factor in the Mammalian Peripheral Nervous SystemJournal of Biological Chemistry, 2004